{"disease":{"id":"infantile-spasms","name":"Infantile spasms","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":1,"trial_count":0},"drugs":{"marketed":[],"pipeline":[{"drug_id":"cosyntropin","indication_name":"Infantile spasms","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"COSYNTROPIN","company_name":"","drug_phase":"marketed","molecular_target":"MC2 receptor","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06819670","title":"A Study to Prevent Infantile Spasms Relapse","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04086992","title":"Decreasing Parental Stress of Caregivers of Infants With Infantile Spasms by Using Telemedicine Technology","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03976076","title":"A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"Bio-Pharm Solutions Co., Ltd.","has_results":true},{"nct_id":"NCT02953548","title":"Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT02954887","title":"Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT02829827","title":"A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":false},{"nct_id":"NCT02299115","title":"Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}